US$ 23.84
wells pharmacy network tirzepatide Zepbound® - Injectable Lilly releases Zepbound® (tirzepatide) single-dose
Description
Package Version 1 , 14 (2020)

Torgersen J et al

Adverse effects observed in trials include nausea, vomiting, gallbladder disease, dehydration, and potential pancreatitis

The dietary goal isn't restriction for its own sake
Given the frequent overlap among clinical phenotypes, the choice of therapy should arise from a shared decision-making process between clinician and patient, prioritizing the most clinically relevant complication and the most meaningful one to the individual
